Paraprotein interference with turbidimetric gentamicin assay

被引:0
|
作者
Dimeski, Goce [1 ]
Bassett, Kendra [1 ]
Brown, Nigel [1 ]
机构
[1] Princess Alexandra Hosp, Dept Chem Pathol, Pathol Queensland, Brisbane, Qld 4102, Australia
关键词
turbidimetry; IgM; paraprotein; interference; MONOCLONAL IGM;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Introduction: Gentamicin due to its low level of resistance and rapid bactericidal activity is commonly used to treat gram-negative bacteria. However, due to its toxic effects it needs to be monitored. To date, no interference has been reported with gentamicin assays. Materials and methods: A patient with leg cellulitis and sepsis received a single dose of gentamicin and a sample was sent for gentamicin analysis. The sample showed high blank absorbance readings on Beckman DxC800 and DC800 analysers with various dilutions. A second sample was received and analysed on a Roche Cobas system to obtain a result. A third sample was received 107 hours later with the same results and this sample was then analysed neat and post ethanol precipitation on all the turbidimetric assays available on the DxC800 analyser. Results: The high blank absorbance was observed upon addition of the reactive reagents due to protein precipitation. Although not obvious from the patient protein results, it was shown the presence of high IgM paraprotein, 18.9 g/L (reference range 0.4-2.3 g/L) was the cause of precipitation, giving high blank readings. Of all the other turbidimetric assays, only vancomicin and valproate showed similar high blank absorbance readings. To be able to provide more rapid results it was shown ethanol could be used as a precipitant of proteins in both calibrators and patient samples with acceptable recovery. Conclusion: IgM paraprotein was identified as the cause of interference with the gentamicin, vancomicin and valproate assays. Protein interference in these assays can be overcome by precipitation with ethanol.
引用
收藏
页码:117 / 124
页数:8
相关论文
共 50 条
  • [1] TURBIDIMETRIC ASSAY OF GENTAMICIN FOR MONITORING OF PATIENTS RECEIVING GENTAMICIN THERAPY
    VANCAEKENBERGHE, D
    BRASSEUR, M
    LECLERCQ, R
    MEDECINE ET MALADIES INFECTIEUSES, 1984, 14 (02): : 50 - 53
  • [2] Paraprotein interference in an assay of conjugated billrubin
    Nauti, A
    Barassi, A
    Merlini, G
    d'Eril, GVM
    CLINICAL CHEMISTRY, 2005, 51 (06) : 1076 - 1077
  • [3] Paraprotein interference in the Olympus conjugated bilirubin (CB) assay
    d'Eril, GM
    Nauti, A
    Barassi, A
    Merlini, G
    CLINICAL CHEMISTRY, 2005, 51 : A103 - A103
  • [4] Negative thyrotropin assay interference associated with an IgGκ paraprotein
    Luzzi, VI
    Scott, MG
    Gronowski, AM
    CLINICAL CHEMISTRY, 2003, 49 (04) : 709 - 710
  • [5] HETEROPHILE ANTIBODY INTERFERENCE IN A GENTAMICIN ASSAY
    McCann, Lindsay
    McDaniel, Cara
    CRITICAL CARE MEDICINE, 2012, 40 (12) : U335 - U335
  • [6] TURBIDIMETRIC RATE INHIBITION ASSAY FOR GENTAMICIN USING A MONOCLONAL-ANTIBODY
    LUCAS, F
    BEDEVIA, J
    SHENKIN, M
    LANDRUM, E
    CLINICAL CHEMISTRY, 1988, 34 (06) : 1256 - 1256
  • [7] Paraprotein Interference in Immunoassays
    LeGatt, Donald F.
    Higgins, Trefor N.
    THERAPEUTIC DRUG MONITORING, 2015, 37 (03) : 417 - 417
  • [8] TURBIDIMETRIC ASSAY
    不详
    METHODS IN MEDICAL RESEARCH, 1948, 1 (01) : 22 - 24
  • [9] Detecting paraprotein interference on a direct bilirubin assay by reviewing the photometric reaction data
    Garcia-Gonzalez, Elena
    Aramendia, Maite
    Gonzalez-Tarancon, Ricardo
    Romero-Sanchez, Naiara
    Rello, Luis
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (08) : 1178 - 1185
  • [10] THE TURBIDIMETRIC ASSAY OF HYALURONIDASE
    TOLKSDORF, S
    MCCREADY, MH
    MCCULLAGH, DR
    SCHWENK, E
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1949, 34 (01): : 74 - 89